320 related articles for article (PubMed ID: 28427285)
1. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
[TBL] [Abstract][Full Text] [Related]
2. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
Nguyen TV; Reuter JM; Gaikwad NW; Rotroff DM; Kucera HR; Motsinger-Reif A; Smith CP; Nieman LK; Rubinow DR; Kaddurah-Daouk R; Schmidt PJ
Transl Psychiatry; 2017 Aug; 7(8):e1193. PubMed ID: 28786978
[TBL] [Abstract][Full Text] [Related]
3. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR
N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325
[TBL] [Abstract][Full Text] [Related]
4. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.
Dubey N; Hoffman JF; Schuebel K; Yuan Q; Martinez PE; Nieman LK; Rubinow DR; Schmidt PJ; Goldman D
Mol Psychiatry; 2017 Aug; 22(8):1172-1184. PubMed ID: 28044059
[TBL] [Abstract][Full Text] [Related]
5. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
Comasco E; Kopp Kallner H; Bixo M; Hirschberg AL; Nyback S; de Grauw H; Epperson CN; Sundström-Poromaa I
Am J Psychiatry; 2021 Mar; 178(3):256-265. PubMed ID: 33297719
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.
Baller EB; Wei SM; Kohn PD; Rubinow DR; Alarcón G; Schmidt PJ; Berman KF
Am J Psychiatry; 2013 Mar; 170(3):305-14. PubMed ID: 23361612
[TBL] [Abstract][Full Text] [Related]
9. Subgenual cingulate resting regional cerebral blood flow in premenstrual dysphoric disorder: differential regulation by ovarian steroids and preliminary evidence for an association with expression of ESC/E(Z) complex genes.
Wei SM; Baller EB; Martinez PE; Goff AC; Li HJ; Kohn PD; Kippenhan JS; Soldin SJ; Rubinow DR; Goldman D; Schmidt PJ; Berman KF
Transl Psychiatry; 2021 Apr; 11(1):206. PubMed ID: 33833224
[TBL] [Abstract][Full Text] [Related]
10. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
Lee EE; Nieman LK; Martinez PE; Harsh VL; Rubinow DR; Schmidt PJ
J Clin Endocrinol Metab; 2012 Jun; 97(6):1887-96. PubMed ID: 22466349
[TBL] [Abstract][Full Text] [Related]
11. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
[TBL] [Abstract][Full Text] [Related]
12. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
[TBL] [Abstract][Full Text] [Related]
13. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
[TBL] [Abstract][Full Text] [Related]
15. Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder.
Di Florio A; Alexander D; Schmidt PJ; Rubinow DR
Depress Anxiety; 2018 Dec; 35(12):1168-1177. PubMed ID: 30184299
[TBL] [Abstract][Full Text] [Related]
16. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
[TBL] [Abstract][Full Text] [Related]
17. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
[No Abstract] [Full Text] [Related]
18. Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics.
Pincus SM; Alam S; Rubinow DR; Bhuvaneswar CG; Schmidt PJ
J Psychiatr Res; 2011 Mar; 45(3):386-94. PubMed ID: 20708199
[TBL] [Abstract][Full Text] [Related]
19. Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder.
Ko CH; Wong TH; Suen JL; Lin PC; Long CY; Yen JY
J Psychiatr Res; 2024 Jan; 169():307-317. PubMed ID: 38070471
[TBL] [Abstract][Full Text] [Related]
20. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
